amygdalin and Palmoplantaris Pustulosis

amygdalin has been researched along with Palmoplantaris Pustulosis in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (16.67)	29.6817
2010's	3 (50.00)	24.3611
2020's	2 (33.33)	2.80

Authors

Authors	Studies
Lé, AM; Torres, T	1
Gago-López, N; Lagunas Arnal, C; Perez, JJ; Wagner, EF	1
Perez, JJ	1
Baroni, A; De Gregorio, V; Donnarumma, G; Paoletti, I; Perez, JJ; Tufano, MA	1
Hackemer, P; Otlewska, A; Zdrojewicz, Z	1
Abdelnoor, AM	1

Reviews

4 review(s) available for amygdalin and Palmoplantaris Pustulosis

Article	Year
New Topical Therapies for Psoriasis. American journal of clinical dermatology, 2022, Volume: 23, Issue:1 Topics: Administration, Topical; Aminopyridines; Amygdalin; Benzamides; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cyclopropanes; Dermatologic Agents; Humans; Interleukin-2; MicroRNAs; Nitriles; Phosphodiesterase 4 Inhibitors; Piperidines; Psoriasis; Pyrazoles; Pyrimidines; Resorcinols; Stilbenes	2022
Amygdalin analogs for the treatment of psoriasis. Future medicinal chemistry, 2013, Volume: 5, Issue:7 Topics: Amygdalin; Animals; Antibodies, Monoclonal; Antineoplastic Agents, Phytogenic; Humans; Phosphodiesterase 4 Inhibitors; Protein Kinase Inhibitors; Psoriasis; Structure-Activity Relationship; T-Lymphocytes	2013
[Amygdalin - structure and clinical significance]. Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 2015, Volume: 38, Issue:227 Topics: Amygdalin; Antineoplastic Agents, Phytogenic; Humans; Kidney Failure, Chronic; Molecular Structure; Neoplasms; Psoriasis	2015
Patented small molecules against psoriasis. Expert opinion on therapeutic patents, 2009, Volume: 19, Issue:8 Topics: Amygdalin; Angiogenesis Inhibitors; Humans; Interleukin-15; Lymphocyte Activation; Patents as Topic; Psoriasis; T-Lymphocytes	2009

Other Studies

2 other study(ies) available for amygdalin and Palmoplantaris Pustulosis

Article	Year
Topical application of an amygdalin analogue reduces inflammation and keratinocyte proliferation in a psoriasis mouse model. Experimental dermatology, 2021, Volume: 30, Issue:11 Topics: Administration, Topical; Amygdalin; Animals; Cell Proliferation; Disease Models, Animal; Dosage Forms; Keratinocytes; Mice; Psoriasis	2021
Amygdalin analogues inhibit IFN-γ signalling and reduce the inflammatory response in human epidermal keratinocytes. Inflammation, 2013, Volume: 36, Issue:6 Topics: Amygdalin; Antineoplastic Agents, Phytogenic; Enzyme Inhibitors; HSP70 Heat-Shock Proteins; Humans; Inflammation; Intercellular Adhesion Molecule-1; Interferon-gamma; Interleukin-23; Interleukin-6; Interleukin-8; Keratinocytes; Nitriles; Peptide T; Psoriasis; Signal Transduction; STAT3 Transcription Factor; Tumor Necrosis Factor-alpha	2013

Article

Year

Topical application of an amygdalin analogue reduces inflammation and keratinocyte proliferation in a psoriasis mouse model.

Experimental dermatology, 2021, Volume: 30, Issue:11

Topics: Administration, Topical; Amygdalin; Animals; Cell Proliferation; Disease Models, Animal; Dosage Forms; Keratinocytes; Mice; Psoriasis

2021

Amygdalin analogues inhibit IFN-γ signalling and reduce the inflammatory response in human epidermal keratinocytes.

Inflammation, 2013, Volume: 36, Issue:6

Topics: Amygdalin; Antineoplastic Agents, Phytogenic; Enzyme Inhibitors; HSP70 Heat-Shock Proteins; Humans; Inflammation; Intercellular Adhesion Molecule-1; Interferon-gamma; Interleukin-23; Interleukin-6; Interleukin-8; Keratinocytes; Nitriles; Peptide T; Psoriasis; Signal Transduction; STAT3 Transcription Factor; Tumor Necrosis Factor-alpha

2013